Subject(s)
Intestinal Perforation , Aged, 80 and over , Humans , Intestinal Perforation/etiology , NonagenariansABSTRACT
OBJECTIVES: To determine the prevalence of patients with bladder catheterization in a geriatrics service and to analyze the factors associated with the use of urinary catheterization in hospitalized elderly people. MATERIAL AND METHOD: This descriptive and retrospective study (January to December 2019) included all the patients admitted to a geriatric service, with bladder catheterization during their hospital admission. Sociodemographic and clinical data were collected. RESULTS: In 2019, 10.20% of the patients admitted required urinary catheters. Most of these patients were males (60.6%), with an average age of 86.5 years (SD: 8.65). 43.4% of the urinary catheters that were placed temporarily were indicated in the geriatric unit, 28.9% in another medical service and 26.3% in the emergency department. The median of days with a urinary catheter was 7.5 days. The most common reason to indicate a urinary catheter was acute urinary retention (AUR) (67.7%). At hospital discharge, 22.3% of the patients needed to continue with a urinary catheter at home, without needing it prior to admission. CONCLUSIONS: In our study, a high percentage of bladder catheterization was needed during the hospitalization, the most common cause being AUR. The average use (in days) of urinary catheters is high, with the consequent risk of nosocomial urinary tract infections. It is necessary to improve the prescribing habits of urinary catheterization and its early withdrawal through specific educational efforts and avoiding their inappropriate use.
Subject(s)
Urinary Catheterization , Urinary Tract Infections , Aged , Aged, 80 and over , Humans , Male , Retrospective Studies , Urinary Bladder , Urinary Catheters/adverse effects , Urinary Tract Infections/epidemiology , Urinary Tract Infections/prevention & controlABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Vitamin D/analysis , Hip Fractures/physiopathology , Vitamin D Deficiency/epidemiology , Bone Density Conservation Agents/analysis , Hyperparathyroidism, Secondary/epidemiology , Muscle Weakness/epidemiologyABSTRACT
Objetivos. Conocer la prevalencia del síndrome metabólico (SM) según las definiciones del National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III ) y la International Diabetes Federation (IDF) y su relación con la enfermedad cardiovascular (ECV) en los ancianos hospitalizados. Material y método. Estudio descriptivo, prospectivo realizado entre febrero y marzo del 2011. Se estudiaron 200 pacientes consecutivos hospitalizados. Se registraron las variables sociodemográficas, clínicas, bioquímicas y antecedentes personales. Resultados. La prevalencia del SM fue del 65% (NCEP-ATP III ) y 67,5% (IDF), siendo mayor en las mujeres (NCEP-ATP III = 72,8%; IDF = 73,6%), que en los varones (NCEP-ATP III = 50,7%; IDF = 56,3%). La edad media de los pacientes diagnosticados de SM según ambos criterios diagnósticos fue parecido: 84,7 años. El SM no se asoció a una mayor prevalencia de ECV. Conclusiones. El SM tiene una elevada prevalencia en los ancianos hospitalizados, siendo mayor en mujeres, tanto con los criterios NCEP-ATP III como con los de la IDF. En nuestra población el SM no se asoció a una mayor prevalencia de ECV (AU)
Objectives. To determine the prevalence of metabolic syndrome (MS) according to the definitions of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the International Diabetes Federation (IDF) and its relation to cardiovascular disease (CVD) in hospitalized elderly patients. Material and methods. This descriptive and prospective study (February-March 2011) included 200 consecutive patients hospitalized in a Geriatric Department. Sociodemographic, clinical and biochemical data was collected. Results. The prevalence of MS was 65% (NCEP-ATP III) and 67.5% (IDF) and was greater in women (NCEP-ATP III=72.8%, IDF=73.6%) than in men (NCEP-ATP III=50.7%; IDF=56.3%). The mean age of patients diagnosed with MS by both diagnostic criteria were similar: 84.7 years. MS was not associated with an increased prevalence of CVD. Conclusions. MS is highly prevalent in elderly hospitalized patients, being higher in women, with both diagnostic criteria (NCEP- ATP III and IDF). In our population the MS was not associated with an increased prevalence of CVD (AU)
Subject(s)
Humans , Male , Female , Metabolic Syndrome/epidemiology , Metabolic Syndrome/prevention & control , Arterial Pressure/physiology , Hyperlipidemias/epidemiology , Hyperlipidemias/prevention & control , Prospective Studies , Repertory, Barthel , Diabetes Mellitus/epidemiology , Diabetes Mellitus/prevention & control , TriglyceridesABSTRACT
OBJECTIVES: To determine the prevalence of metabolic syndrome (MS) according to the definitions of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the International Diabetes Federation (IDF) and its relation to cardiovascular disease (CVD) in hospitalized elderly patients. MATERIAL AND METHODS: This descriptive and prospective study (February-March 2011) included 200 consecutive patients hospitalized in a Geriatric Department. Sociodemographic, clinical and biochemical data was collected. RESULTS: The prevalence of MS was 65% (NCEP-ATP III) and 67.5% (IDF) and was greater in women (NCEP-ATP III=72.8%, IDF=73.6%) than in men (NCEP-ATP III=50.7%; IDF=56.3%). The mean age of patients diagnosed with MS by both diagnostic criteria were similar: 84.7 years. MS was not associated with an increased prevalence of CVD. CONCLUSIONS: MS is highly prevalent in elderly hospitalized patients, being higher in women, with both diagnostic criteria (NCEP- ATP III and IDF). In our population the MS was not associated with an increased prevalence of CVD.
